Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MAGAA
Magna-Lab
$0.57
-3.4%
$0.71
$0.11
$2.00
$672K7.513,117 shs24,039 shs
OREXQ
Orexigen Therapeutics
$0.01
+35.9%
$0.01
$0.00
$0.16
$100K4.9880,439 shs60,300 shs
Rennova Health, Inc. stock logo
RNVA
Rennova Health
$0.00
$0.00
$0.00
$4.06M14.7646.72 million shs215.48 million shs
VRSEF
Verisante Technology
$0.00
$0.01
$0.00
$0.01
$101K19.7368 shsN/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MAGAA
Magna-Lab
0.00%+180.95%-40.40%+96.67%+578.94%
OREXQ
Orexigen Therapeutics
0.00%0.00%0.00%0.00%0.00%
Rennova Health, Inc. stock logo
RNVA
Rennova Health
0.00%0.00%0.00%0.00%0.00%
VRSEF
Verisante Technology
0.00%0.00%-54.00%-77.00%-62.90%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
MAGAA
Magna-Lab
N/AN/AN/AN/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
N/AN/AN/AN/AN/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
MAGAA
Magna-Lab
N/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
N/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
MAGAA
Magna-Lab
N/AN/AN/AN/A($1.52) per shareN/A
OREXQ
Orexigen Therapeutics
$33.71M0.00N/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
$13.04M0.00N/AN/AN/ANaN
VRSEF
Verisante Technology
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
MAGAA
Magna-Lab
-$130K$0.183.17N/AN/A-12.32%42,399.99%N/A
OREXQ
Orexigen Therapeutics
-$24.52MN/A0.00N/AN/AN/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
-$3.29MN/A0.00N/AN/A11.61%-8.49%11.51%N/A
VRSEF
Verisante Technology
-$70KN/A0.00N/AN/AN/A-277.19%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
MAGAA
Magna-Lab
N/AN/AN/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
N/AN/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
MAGAA
Magna-Lab
N/AN/AN/A
OREXQ
Orexigen Therapeutics
N/AN/AN/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
N/A
0.12
0.11
VRSEF
Verisante Technology
N/A
1.40
1.40

Ownership

Institutional Ownership

CompanyInstitutional Ownership
MAGAA
Magna-Lab
N/A
OREXQ
Orexigen Therapeutics
N/A
Rennova Health, Inc. stock logo
RNVA
Rennova Health
N/A
VRSEF
Verisante Technology
N/A

Insider Ownership

CompanyInsider Ownership
MAGAA
Magna-Lab
15.30%
OREXQ
Orexigen Therapeutics
13.30%
Rennova Health, Inc. stock logo
RNVA
Rennova Health
55.52%
VRSEF
Verisante Technology
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
MAGAA
Magna-Lab
N/A1.18 millionN/ANot Optionable
OREXQ
Orexigen Therapeutics
N/A18.89 millionN/ANot Optionable
Rennova Health, Inc. stock logo
RNVA
Rennova Health
8540.55 billion18.04 billionNot Optionable
VRSEF
Verisante Technology
N/A43.94 millionN/ANot Optionable

RNVA, VRSEF, OREXQ, and MAGAA Headlines

SourceHeadline
Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt TransactionVerisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction
accesswire.com - March 30 at 6:30 AM
Verisante: Q4 Earnings SnapshotVerisante: Q4 Earnings Snapshot
sfgate.com - March 29 at 6:07 AM
Verisante Technology, Inc. Announces Shares for Debt AgreementsVerisante Technology, Inc. Announces Shares for Debt Agreements
accesswire.com - March 14 at 5:20 PM
Verisante Technology, Inc. Announces 2023 AGM ResultsVerisante Technology, Inc. Announces 2023 AGM Results
finance.yahoo.com - December 21 at 5:26 AM
Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt TransactionVerisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction
finance.yahoo.com - October 5 at 11:09 PM
Verisante Technology Inc. Announces Shares for Debt AgreementsVerisante Technology Inc. Announces Shares for Debt Agreements
finance.yahoo.com - September 8 at 3:42 AM
Verisante: Q2 Earnings SnapshotVerisante: Q2 Earnings Snapshot
wtop.com - August 15 at 9:14 PM
Latest Technology NewsLatest Technology News
prweek.com - March 30 at 2:19 PM
Verisante Technology, Inc. Announces Exchange Acceptance for Shares for Debt TransactionsVerisante Technology, Inc. Announces Exchange Acceptance for Shares for Debt Transactions
finance.yahoo.com - November 23 at 6:55 PM
Verisante: Q3 Earnings SnapshotVerisante: Q3 Earnings Snapshot
sfgate.com - November 18 at 9:42 AM
Verisante Technology, Inc.: Verisante Technology Inc. Announces Proposed Shares for Debt TransactionVerisante Technology, Inc.: Verisante Technology Inc. Announces Proposed Shares for Debt Transaction
finanznachrichten.de - October 22 at 9:24 AM
Verisante Technology Inc. Announces Proposed Shares for Debt TransactionVerisante Technology Inc. Announces Proposed Shares for Debt Transaction
finance.yahoo.com - October 19 at 6:38 PM
Verisante Technology Inc. Announces Closing Non-Brokered Private PlacementVerisante Technology Inc. Announces Closing Non-Brokered Private Placement
apnews.com - July 13 at 7:05 PM
Verisante Technology, Inc. Announces AGM ResultsVerisante Technology, Inc. Announces AGM Results
apnews.com - July 7 at 11:10 PM
Verisante Technology, Inc.: Verisante Technology Inc. Announces Non-Brokered Private PlacementVerisante Technology, Inc.: Verisante Technology Inc. Announces Non-Brokered Private Placement
finanznachrichten.de - June 30 at 8:19 PM
Verisante Technology Inc. Announces Non-Brokered Private PlacementVerisante Technology Inc. Announces Non-Brokered Private Placement
bignewsnetwork.com - June 30 at 8:19 PM
Verisante Share Consolidation EffectiveVerisante Share Consolidation Effective
finance.yahoo.com - June 23 at 5:29 PM
VERISANTE ANNOUNCES SHARE CONSOLIDATIONVERISANTE ANNOUNCES SHARE CONSOLIDATION
finance.yahoo.com - June 14 at 6:45 PM
VERISANTE TECHNOLOGY INC. ANNOUNCES SHARE ISSUANCEVERISANTE TECHNOLOGY INC. ANNOUNCES SHARE ISSUANCE
finance.yahoo.com - June 6 at 4:39 AM
Verisante: Q1 Earnings SnapshotVerisante: Q1 Earnings Snapshot
apnews.com - May 31 at 4:48 PM
IIROC Trading Resumption - VRS.HIIROC Trading Resumption - VRS.H
finance.yahoo.com - May 30 at 6:41 PM
VERISANTE ANNOUNCES REINSTATEMENT TO TRADE AND CORPORATE UPDATEVERISANTE ANNOUNCES REINSTATEMENT TO TRADE AND CORPORATE UPDATE
finance.yahoo.com - May 27 at 11:31 PM
Verisante Technology Inc (VRSEF)Verisante Technology Inc (VRSEF)
nasdaq.com - January 23 at 8:37 PM
Verisante Technology Dividend Per Share (TTM)Verisante Technology Dividend Per Share (TTM)
ycharts.com - December 19 at 12:06 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Magna-Lab

OTCMKTS:MAGAA
Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.

Orexigen Therapeutics

OTCMKTS:OREXQ
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Rennova Health logo

Rennova Health

OTCMKTS:RNVA
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

Verisante Technology

OTCMKTS:VRSEF
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.